Arcturus Therapeutics Holdings (ARCT) Equity Income (2018 - 2022)
Arcturus Therapeutics Holdings (ARCT) reported Equity Income of -$131000.0 for Q2 2022, up 60.06% on a YoY basis from -$81843.8 in Q2 2021, and up 65.89% quarter-over-quarter from -$384000.0 in Q1 2022.
Arcturus Therapeutics Holdings (ARCT) Equity Income (2018 - 2022) Analysis & Trends
Arcturus Therapeutics Holdings has reported Equity Income for 5 years, with the latest figure at -$131000.0 in Q2 2022.
- For the quarter ending Q2 2022, Equity Income rose 60.06% year-over-year to -$131000.0; the trailing twelve-month figure through Dec 2022 stood at -$515000.0 (down 200.0% YoY), and the FY2022 full-year result was -$515000.0, down 200.0% from the prior year.
- Equity Income for Q2 2022 stood at -$131000.0, up from -$384000.0 in the prior quarter.
- The five-year high for Equity Income was $1.2 million in Q1 2021, with the low at -$384000.0 in Q1 2022.
- Historically, Equity Income has averaged -$46000.0 across 5 years, with a median of -$143000.0 in 2021.
- The largest YoY upside for Equity Income was 865.64% in 2021 against a maximum downside of 228.0% in 2021.
- Arcturus Therapeutics Holdings' Equity Income stood at -$255000.0 in 2018, then soared by 81.57% to -$47000.0 in 2019, then plunged by 112.77% to -$100000.0 in 2020, then sank by 55.0% to -$155000.0 in 2021, then advanced by 15.48% to -$131000.0 in 2022.
- The last three Equity Income figures came in at -$131000.0 (Q2 2022), -$384000.0 (Q1 2022), and -$155000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -131,000.00 |
| Mar 31, 2022 | -384,000.00 |
| Dec 31, 2021 | -155,000.00 |
| Sep 30, 2021 | -250,000.00 |
| Jun 30, 2021 | -328,000.00 |
| Mar 31, 2021 | 1.25 Mn |
| Jun 30, 2020 | -100,000.00 |
| Mar 31, 2020 | -163,000.00 |
| Dec 31, 2019 | -47,000.00 |
| Sep 30, 2019 | 303,000.00 |
| Mar 31, 2019 | -288,000.00 |
| Dec 31, 2018 | -255,000.00 |
| Sep 30, 2018 | -47,000.00 |
| Jun 30, 2018 | -47,000.00 |